Medical Health & Life Science Research News

Ophthalmic drugs industry analyzed in new research report

Ophthalmic drugs industry analyzed in new research report

Ophthalmic Drugs and device market is expected to grow at a CAGR of 5.78% during 2017-2025 and is estimated to reach $87343.53 million by 2025. In 2016, the global Ophthalmic Drugs and Devices Market was valued at $52866 million.

- Agency -.

The rising eye related disorders in the world, changing lifestyle, and rising healthcare expenditure are the major driving factors in the growth of the global ophthalmic drug and devices market.

Company Covered: ABBOTT LABORATORIES, AKORN, ALLERGAN INC., BAYER AG, CIPLA PHARMACEUTICALS, EYEGATE PHARMACEUTICALS, EYEMED, GLAXOSMITHKLINE, JOHNSON AND JOHNSON, LPATH INCORPORATED, MERCK & CO., BIOTECH VISIONCARE, CARL ZEISS MEDIATEK AG, ELLEX, NIDEK CO.

- Agency -.

LTD, NOVARTIS AG, PFIZER INC., REGENERON, ROCHE HOLDING AG, SENJU PHARMACEUTICAL CO., LTD, SUN PHARMACEUTICALS INDUSTRIES, LTD., SANTEN PHARMACEUTICAL CO.LTD, STAAR SURGICAL COMPANY, TOPCON CORPORATION, VALEANT, VISIONCARE OPHTHALMIC TECHNOLOGIES, ZIEMER OPHTHALMIC SYSTEMS AG, HAAG-STREIT GROUP, IRIDEX CORPORATION.

Complete report on Ophthalmic Drugs Market spread across 172 pages, profiling 29 companies and supported with 178 tables and figures is now available @ www.reportsnreports.com/contacts/d…spx?name=1151633

The ophthalmic drugs & devices market is segmented into various diagnostic and monitoring equipment, surgical devices, and vision care products. All such categorization being furthermore divided into device types, technology and features of the devices.

Well-known drugs are going off patent and key players affected by the delay in new drugs coming into the market are the two factors restricting the growth of the market. The market faces challenges in risk associated with the ocular diseases and lack of awareness among people regarding ophthalmology.

REGIONAL INSIGHTS:

Geographically global ophthalmic drugs & devices market is segmented into North America, Europe, Asia-Pacific, and Rest of World. Currently, North America holds a massive market share followed by Europe and Asia-Pacific.

Due to rising geriatric population, increase in strategic initiatives by large market players present in the region and increasing prevalence of ocular diseases, the North America ophthalmic drugs & devices market holds high growth prospects in the near futureHowever, over the forecasted period Asia-Pacific is expected to grow at the highest CAGR. APAC market is majorly driven by the rising prevalence and increasing facilities for eye treatment in hospitals.

Access Report at www.reportsnreports.com/purchase.aspx?name=1151633

COMPETITIVE INSIGHTS:

On the basis of devices, this market is dominated by global players like Alex and Topcon Corporation.Global ophthalmic drugs market has a large number of market players but, the market is dominated by companies like Novartis AG and Santen.

Table of Contents:

  1. RESEARCH SCOPE
  2. RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
  4. MARKET OVERVIEW
  5. MARKET SEGMENTATION
  6. KEY ANALYTICS
  7. GEOGRAPHICAL ANALYSIS
  8. COMPETITIVE ANALYSIS
  9. COMPANY PROFILES

LIST OF TABLES:

TABLE 1 GLOBAL OPHTHALMIC DRUGS AND DEVICE MARKET BY PRODUCT 2017-2025 ($ MILLION)

TABLE 2 TOP OPHTHALMIC DRUGS BRANDS

TABLE 3 DRUGS AND DEVICES APPROVED BY FDA

TABLE 4 SYMPTOMS OF SOME COMMON CAUSES OF LOSS OF VISION IN ELDERLY PATIENTS

TABLE 5 EYE DRUGS GONE PATENT OFF

TABLE 6 FACTS ABOUT CATARACT SURGERIES FROM DEVELOPING ECONOMIES

TABLE 7 GLOBAL OPHTHALMIC DEVICE MARKET BY GEOGRAPHY 2017-2025($MILLION)

TABLE 8 GLOBAL OPHTHALMIC DEVICE MARKET 2017-2025 ($ MILLION)

LIST OF FIGURES:

FIGURE 1 KEY FINDINGS OF THE REPORT

FIGURE 2 GLOBAL GERIATRIC POPULATION (65+) 2015 & 2020 (MILLION)

FIGURE 3 PROJECTIONS FOR THE PROPORTION OF GLOBAL GERIATRIC (60+) POPULATION

FIGURE 4 WORLDWIDE PREVALENCE OF PRESBYOPIA (BILLION)

FIGURE 5 PREVALENCE OF GLAUCOMA AT GLOBAL LEVEL (MILLION)

FIGURE 6 GLOBAL HEALTHCARE EXPENDITURE (% OF GDP) 2012-2014

FIGURE 7 HEALTHCARE EXPENDITURE OF DEVELOPED ECONOMIES AS % OF THEIR GDP IN 2014

FIGURE 8 HEALTHCARE EXPENDITURE OF DEVELOPING ECONOMIES AS % OF THEIR GDP IN 2014

FIGURE 9 HEALTHCARE EXPENDITURE (AS % OF GDP) OF MAJOR APAC COUNTRIES IN 2014

FIGURE 10 GROWTH IN GERIATRIC POPULATION FROM 2010 TO 2015(%)

FIGURE 11 RISK ASSOCIATED WITH THE OCULAR DISEASES

FIGURE 12 CAUSES OF BLINDNESS WORLDWIDE

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.